Yuyu Pharma (000220) — Cash Flow Quality Index
Latest as of September 2025:
0.21x
Yuyu Pharma (000220) has a Cash Flow Quality Index of 0.21x as of September 2025. Operating cash flow of ₩836.62 Million is below net income of ₩3.98 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Yuyu Pharma cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.21x
Operating CF / Net Income
Operating Cash Flow
₩836.62 Million
KRW
Net Income
₩3.98 Billion
KRW
Data as of
Sep 2025
Most recent filing
Yuyu Pharma Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Yuyu Pharma across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 000220 operating cash flow.
Annual Cash Flow Quality Index for Yuyu Pharma (2011–2024)
Year-by-year earnings quality comparison for Yuyu Pharma.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.86x | ₩24.95 Billion | ₩8.72 Billion | ▲ +237.6% |
| 2020 | -2.08x | ₩-2.67 Billion | ₩1.28 Billion | ▼ -174.5% |
| 2019 | 2.79x | ₩13.19 Billion | ₩4.72 Billion | ▲ +83.7% |
| 2018 | 1.52x | ₩6.11 Billion | ₩4.02 Billion | ▲ +1584.3% |
| 2017 | 0.09x | ₩561.35 Million | ₩6.22 Billion | ▼ -94.6% |
| 2016 | 1.67x | ₩9.82 Billion | ₩5.89 Billion | ▲ +450.8% |
| 2013 | -0.48x | ₩-775.17 Million | ₩1.63 Billion | ▼ -120.1% |
| 2012 | 2.36x | ₩6.51 Billion | ₩2.76 Billion | ▼ -47.8% |
| 2011 | 4.52x | ₩6.67 Billion | ₩1.48 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.